Biliary Tract Cancer Clinical Trials in Osaka
2 recruitingOsaka, Japan
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
Biliary Tract Cancer
AstraZeneca1,100 enrolled168 locationsNCT07221253
Recruiting
Phase 1
AB122 Platform Study
Colorectal, CancerEsophageal CancerGastric Cancer+6 more
Taiho Pharmaceutical Co., Ltd.917 enrolled9 locationsNCT04999761